Benecchi Christopher
Insider CIK 1881403 · SAGE Chief Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SAGE Sage Therapeutics, Inc. | D To issuer deriv | 2025-07-31 | 2025-07-31 | 12,500 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | D To issuer deriv | 2025-07-31 | 2025-07-31 | 40,000 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | D To issuer | 2025-07-31 | 2025-07-31 | 36,375 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | D To issuer | 2025-07-31 | 2025-07-31 | 28,053 | — | $0 | 0 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2025-04-10 | 2025-04-11 | 3,255 | — | $0 | 47,170 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2025-04-10 | 2025-04-11 | 2,712 | — | $0 | 49,089 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2025-04-10 | 2025-04-11 | 661 | $6.91 | $4.6K | 48,428 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2025-04-10 | 2025-04-11 | 793 | $6.91 | $5.5K | 46,377 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2025-02-13 | 2025-02-14 | 822 | $7.18 | $5.9K | 43,915 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2025-01-16 | 2025-01-21 | 40,000 | — | $0 | 40,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2025-01-16 | 2025-01-21 | 20,000 | — | $0 | 44,737 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2024-11-01 | 2024-11-14 | 12,500 | — | $0 | 12,500 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2024-11-01 | 2024-11-14 | 6,250 | — | $0 | 24,737 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2024-08-05 | 2024-08-07 | 16,200 | — | $0 | 23,242 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2024-08-05 | 2024-08-07 | 4,755 | $8.96 | $42.6K | 18,487 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2024-02-13 | 2024-02-15 | 27,000 | — | $0 | 27,000 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2024-02-13 | 2024-02-15 | 13,500 | — | $0 | 19,430 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2023-02-13 | 2023-02-15 | 20,900 | — | $0 | 20,900 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award | 2023-02-03 | 2023-02-07 | 6,750 | — | $0 | 7,379 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | F Tax w/h | 2023-02-03 | 2023-02-07 | 2,119 | $44.16 | $93.6K | 5,260 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2022-06-16 | 2022-06-21 | 9,500 | — | $0 | 9,500 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2022-02-11 | 2022-02-15 | 11,400 | — | $0 | 11,400 | SEC↗ |
| SAGE Sage Therapeutics, Inc. | A Award deriv | 2021-10-01 | 2021-10-04 | 45,000 | — | $0 | 45,000 | SEC↗ |